Cargando…
Foreign investment in emerging legal medicinal cannabis markets: the Jamaica case study
INTRODUCTION: The establishment of a legal market for medicinal cannabis under the Dangerous Drugs Amendment Act 2015 has positioned Jamaica at the forefront of cannabis law reform in the developing world. Many local cannabis businesses have attracted investment from overseas, including from Canada,...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015746/ https://www.ncbi.nlm.nih.gov/pubmed/33794932 http://dx.doi.org/10.1186/s12992-021-00687-3 |
_version_ | 1783673738626072576 |
---|---|
author | Rychert, Marta Emanuel, Machel Anthony Wilkins, Chris |
author_facet | Rychert, Marta Emanuel, Machel Anthony Wilkins, Chris |
author_sort | Rychert, Marta |
collection | PubMed |
description | INTRODUCTION: The establishment of a legal market for medicinal cannabis under the Dangerous Drugs Amendment Act 2015 has positioned Jamaica at the forefront of cannabis law reform in the developing world. Many local cannabis businesses have attracted investment from overseas, including from Canada, US and Europe. AIM: To explore the opportunities and risks of foreign investment in an emerging domestic legal cannabis market in a developing country. METHODS: Thematic analysis of semi-structured face-to-face interviews with 22 key informants (KIs) from the Jamaican government, local cannabis industry, academia and civil society, and field observations of legal and illegal cannabis cultivators. RESULTS: KIs from the Jamaican public agencies and domestic cannabis entrepreneurs saw foreign investment as an essential source of capital to finance the start-up costs of legal cannabis businesses. Local cannabis entrepreneurs prioritised investors with the greatest financial resources, brand reputation and export networks. They also considered how allied an investor was with their business vision (e.g., organic cultivation, medical vs. recreational). The key benefits of partnering with a foreign investor included transfer of technical knowledge and financial capital, which enhanced production, quality assurance and seed-to-sale tracking. Some KIs expressed concern over investors’ focus on increasing production efficiency and scale at the expense of funding research and development (R&D) and clinical trials. KIs from the local industry, government agencies and civil society highlighted the risks of ‘predatory’ shareholder agreements and domestic political interference. Concerns were raised about the impact of foreign investment on the diversity of the domestic cannabis sector in Jamaica, including the commitment to transition traditional illegal small-scale cannabis cultivators to the legal sector. CONCLUSION: While foreign investment has facilitated the commercialisation of the cannabis sector in Jamaica, regulatory measures are also needed to protect the domestic industry and support the transition of small-scale illegal cultivators to the legal regime. Foreign investments may alter the economic, social and political determinants of health in transitioning from illegal to legal cannabis market economy. |
format | Online Article Text |
id | pubmed-8015746 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-80157462021-04-02 Foreign investment in emerging legal medicinal cannabis markets: the Jamaica case study Rychert, Marta Emanuel, Machel Anthony Wilkins, Chris Global Health Research INTRODUCTION: The establishment of a legal market for medicinal cannabis under the Dangerous Drugs Amendment Act 2015 has positioned Jamaica at the forefront of cannabis law reform in the developing world. Many local cannabis businesses have attracted investment from overseas, including from Canada, US and Europe. AIM: To explore the opportunities and risks of foreign investment in an emerging domestic legal cannabis market in a developing country. METHODS: Thematic analysis of semi-structured face-to-face interviews with 22 key informants (KIs) from the Jamaican government, local cannabis industry, academia and civil society, and field observations of legal and illegal cannabis cultivators. RESULTS: KIs from the Jamaican public agencies and domestic cannabis entrepreneurs saw foreign investment as an essential source of capital to finance the start-up costs of legal cannabis businesses. Local cannabis entrepreneurs prioritised investors with the greatest financial resources, brand reputation and export networks. They also considered how allied an investor was with their business vision (e.g., organic cultivation, medical vs. recreational). The key benefits of partnering with a foreign investor included transfer of technical knowledge and financial capital, which enhanced production, quality assurance and seed-to-sale tracking. Some KIs expressed concern over investors’ focus on increasing production efficiency and scale at the expense of funding research and development (R&D) and clinical trials. KIs from the local industry, government agencies and civil society highlighted the risks of ‘predatory’ shareholder agreements and domestic political interference. Concerns were raised about the impact of foreign investment on the diversity of the domestic cannabis sector in Jamaica, including the commitment to transition traditional illegal small-scale cannabis cultivators to the legal sector. CONCLUSION: While foreign investment has facilitated the commercialisation of the cannabis sector in Jamaica, regulatory measures are also needed to protect the domestic industry and support the transition of small-scale illegal cultivators to the legal regime. Foreign investments may alter the economic, social and political determinants of health in transitioning from illegal to legal cannabis market economy. BioMed Central 2021-04-01 /pmc/articles/PMC8015746/ /pubmed/33794932 http://dx.doi.org/10.1186/s12992-021-00687-3 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Rychert, Marta Emanuel, Machel Anthony Wilkins, Chris Foreign investment in emerging legal medicinal cannabis markets: the Jamaica case study |
title | Foreign investment in emerging legal medicinal cannabis markets: the Jamaica case study |
title_full | Foreign investment in emerging legal medicinal cannabis markets: the Jamaica case study |
title_fullStr | Foreign investment in emerging legal medicinal cannabis markets: the Jamaica case study |
title_full_unstemmed | Foreign investment in emerging legal medicinal cannabis markets: the Jamaica case study |
title_short | Foreign investment in emerging legal medicinal cannabis markets: the Jamaica case study |
title_sort | foreign investment in emerging legal medicinal cannabis markets: the jamaica case study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015746/ https://www.ncbi.nlm.nih.gov/pubmed/33794932 http://dx.doi.org/10.1186/s12992-021-00687-3 |
work_keys_str_mv | AT rychertmarta foreigninvestmentinemerginglegalmedicinalcannabismarketsthejamaicacasestudy AT emanuelmachelanthony foreigninvestmentinemerginglegalmedicinalcannabismarketsthejamaicacasestudy AT wilkinschris foreigninvestmentinemerginglegalmedicinalcannabismarketsthejamaicacasestudy |